ArticleNeurology2025
Trends in Status Epilepticus-Related Mortality Disparities in the United States, 1999-2020.
Article in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesStatus epilepticus (SE) is a life-threatening neurologic emergency. Although health disparities in epilepsy are well-documented, disparities in SE mortality are not fully understood. This study analyzes mortality trends and demographics in the United States from 1999 through 2020.
methodsThis was a retrospective study of national data from the Center for Disease Control and Prevention's Wide-Ranging Online Data for Epidemiologic Research platform. We identified annual deaths due to SE for the years 1999 through 2020, stratified by age and by race and ethnicity.
resultsFrom 1999 through 2020, there were 16,491 deaths due to SE in the United States. Overall, there was nearly a 2-fold increase in the age-standardized mortality due to the SE rate from 1999 to 2020 (0.13 per 100,000 persons [95% CI 0.11-0.15] in 1999 to 0.25 per 100,000 persons [95% CI 0.23-0.27] in 2020). This increase was most pronounced among older individuals (aged 75 years and older, followed by ages 50-74 years), and in non-Hispanic Black or African American individuals. DISCUSSION: Over the past 2 decades, deaths attributed to SE have increased. This increase was most pronounced among individuals aged 75 years or older and Black or African Americans. Investigation into the underlying causes of SE-related mortality and reasons for these disparities is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.